Bariatric Surgery Clinical Trial
— MINIBHOOfficial title:
Endocrine and Absorptive Intestinal Function in Patients at Two Years of Bariatric Surgery: Omega Loop Gastric Bypass Versus Roux-en-Y Gastric Bypass
Verified date | September 2019 |
Source | Assistance Publique - Hôpitaux de Paris |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Gastric bypass with omega loop technic (OLGB) seems to be as effective as gastric bypass
roux-en-Y (RYGB the reference) for the management of obesity and type 2 diabetes, but with
less early surgical complications and more undernutrition in long terms.
This study aims to explore the profile of secretion of entero-insular hormone after a meal
test in OLGB patient vs RYGB to understand the mechanisms of the improvement of type 2
diabetes after OLGB.
Secondary objectives are to better understand the absorptive function of the gut after a
gastric bypass, to understand why is there more undernutrition in long term after OLGB than
after RYGB.
Status | Completed |
Enrollment | 30 |
Est. completion date | May 14, 2019 |
Est. primary completion date | May 14, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Roux en Y gastric bypass or omega loop gastric bypass at two years of the surgery (6 months more or less) - 18 years minimum - weight > 40kg Exclusion Criteria: - Type 1 diabetes diagnosed with the positivity of anti Glutamate Acid Decarboxylase (GAD) or anti Ia2 - Treatment with Insulin, Glucagon Like Peptide 1 (GLP1) or anti-DiPeptidyl Peptidase-4 (DPP4) during the study - Unbalanced type 2 diabetes : HbA1c > 8% - Anemia with hemoglobin < 7g/dl - Gut inflammatory disease ; infectious disease, cancer, iatrogenic disease, auto-immune disease - Pregnant or breastfeeding women - allergy to Carmin (E120) - participation to another clinical trial - patient under legal protection |
Country | Name | City | State |
---|---|---|---|
France | AP-HP - Hôpital Européen Georges-Pompidou | Paris | Île-de-France |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris | Société Francophone Nutrition Clinique et Métabolisme |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Kinetic of GLP-1 secretion | Area under the plasma concentration versus time curve of GLP-1 | 0, 15, 30, 60, 90 and 120 minutes after a meal test | |
Secondary | Plasmatic dosage of citrulline | Plasmatic concentration of Citrulline versus enterocyte mass function | Baseline | |
Secondary | Plasmatic dosage of Apolipoprotein B48 | Plasmatic concentration of Apolipoprotein B48 versus enterocyte mass function | Baseline | |
Secondary | Lipidic Absorptive Coefficient | Percentage between lipidic food intakes and lipidic excretion in feces | 1 day | |
Secondary | Protein Absorptive Coefficient | Percentage between protein food intakes and protein excretion in feces | 1 day | |
Secondary | Glucidic Absorptive Coefficient | Percentage between carbohydrate food intakes and carbohydrate excretion in feces | 1 day | |
Secondary | kinetic of GLP-2 secretion | Area under the plasma concentration versus time curve of GLP-2 | 0, 15, 30, 60, 90 and 120 minutes after a meal test | |
Secondary | Kinetic of GIP secretion | Area under the plasma concentration versus time curve of GIP | 0, 15, 30, 60, 90 and 120 minutes after a meal test | |
Secondary | Kinetic of Peptide C secretion | Area under the plasma concentration versus time curve of Peptide C | 0, 15, 30, 60, 90 and 120 minutes after a meal test | |
Secondary | Kinetic of Insulin secretion | Area under the plasma concentration versus time curve of Insulin | 0, 15, 30, 60, 90 and 120 minutes after a meal test | |
Secondary | Kinetic of Glucagon secretion | Area under the plasma concentration versus time curve of Glucagon | 0, 15, 30, 60, 90 and 120 minutes after a meal test | |
Secondary | Kinetic of Glicentin secretion | Area under the plasma concentration versus time curve of Glicentin | 0, 15, 30, 60, 90 and 120 minutes after a meal test | |
Secondary | Kinetic of Glycemia | Area under the plasma concentration versus time curve of glucose | 0, 15, 30, 60, 90 and 120 minutes after a meal test |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04517591 -
Reducing Sedentary Time in Bariatric: The Take a STAND for Health Study
|
N/A | |
Active, not recruiting |
NCT04433338 -
The PREBA Study: Effect of Preoperative Weight Loss With a 14-day Low-calorie Diet on Surgical Procedure and Outcomes in Patients Undergoing RYGB Surgery
|
N/A | |
Completed |
NCT05854875 -
Diabetes Remission After RYGBP and RYGBP With Fundus Resection
|
N/A | |
Recruiting |
NCT06460233 -
Blood Pressure Changes After Bariatric Surgery
|
||
Completed |
NCT00535600 -
Effects of Bariatric Surgery on Insulin
|
||
Withdrawn |
NCT04771247 -
Endoscopic Cardiac Band Ligation for the Management of Refractory GERD After Laparoscopic Sleeve Gastrectomy
|
N/A | |
Not yet recruiting |
NCT03203161 -
Registry on Obesity Surgery in Adolescents
|
||
Enrolling by invitation |
NCT02552433 -
Complications in Body Contouring Surgery
|
||
Completed |
NCT02525016 -
Safety Profile of IntRAvenous Lidocaine Use in Coelioscopic Bariatric Surgery
|
Phase 3 | |
Recruiting |
NCT01984762 -
Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in the Treatment of Type 2 Diabetes Mellitus.
|
N/A | |
Not yet recruiting |
NCT01652105 -
Randomized Trial of Preoperative Diets Before Bariatric Surgery
|
N/A | |
Completed |
NCT00989157 -
Effects of Gastric Bypass on Blood Levels of Duloxetine
|
Phase 3 | |
Completed |
NCT03609632 -
Understanding Hypoglycaemia After Bariatric Surgery
|
N/A | |
Completed |
NCT05454696 -
Online Clinic Pilates Exercises in Patients Undergoing Bariatric Surgery
|
N/A | |
Completed |
NCT04040647 -
Tolerance of Early Postoperative Mobilization and Ambulation
|
||
Recruiting |
NCT04297306 -
Virtual Reality Exercise Gaming in Patients Awaiting Bariatric Surgery
|
N/A | |
Recruiting |
NCT05428618 -
Mobile Application for Bariatric Surgery Patients
|
N/A | |
Not yet recruiting |
NCT03900481 -
Use of an Endoluminal-suturing Device for Endoscopic Gastric Reduction as an Aid for Class I Obesity, or Class II Obesity Without Comorbidity
|
N/A | |
Not yet recruiting |
NCT03975244 -
Semi-supervised Exercise Program Before Bariatric Surgery
|
N/A | |
Recruiting |
NCT06218953 -
The Impact of Preoperative Anemia on Postoperative Anemia and Related Nutrient Abnormalities After Bariatric Surgery
|